CHTH · As filed with the SEC
CNL Healthcare Properties balance sheet, by fiscal year
The statement as CNL Healthcare Properties presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD thousands
| USD thousands | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| Real estate investment properties, net (including VIE $0 and $30,041, respectively) | 1,244,663 | 1,279,137 | 1,313,438 | 1,347,229 |
| Assets held for sale | — | — | 0 | 0 |
| Cash (including VIE $0 and $1,515, respectively) | 44,011 | 54,097 | 69,504 | 53,161 |
| Restricted cash (including VIE $0 and $8, respectively) | 1,602 | 1,791 | 4,070 | 4,520 |
| Other assets (including VIE $0 and $246, respectively) | 19,095 | 19,127 | 36,868 | 18,700 |
| Deferred rent, lease incentives and intangibles, net | 9,970 | 11,386 | 13,423 | 12,970 |
| Total assets | 1,319,341 | 1,365,538 | 1,437,303 | 1,436,580 |
| LIABILITIES AND EQUITY | ||||
| Liabilities: | ||||
| Mortgages and other notes payable, net (including VIE $0 and $20,622, respectively) | 15,748 | 36,569 | 61,773 | 89,400 |
| Credit facilities | 550,389 | 541,840 | 546,100 | 499,728 |
| Accounts payable and accrued liabilities (including VIE $0 and $1,411, respectively) | 28,871 | 31,322 | 30,270 | 29,170 |
| Other liabilities and Due to related parties | — | — | 7,469 | 6,115 |
| Due to related parties | — | — | 1,397 | 1,406 |
| Liabilities associated with assets held for sale | — | — | — | 0 |
| Nonrelated Party | 11,225 | 10,475 | — | — |
| Related Party | 1,327 | 1,292 | — | — |
| Total liabilities | 607,560 | 621,498 | 647,009 | 625,819 |
| Redeemable noncontrolling interest | — | — | — | 520,000 |
| Stockholders' equity: | ||||
| Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 |
| Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding | — | 0 | 0 | 0 |
| Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding | 0 | — | — | — |
| Common stock, $0.01 par value per share, 1,120,000 shares authorized, 187,958 shares issued and 175,274 shares outstanding | 1,739 | 1,739 | 1,740 | 1,740 |
| Capital in excess of par value | 1,515,799 | 1,516,806 | 1,516,926 | 1,516,926 |
| Accumulated income | 60,248 | 74,710 | 100,408 | 101,861 |
| Accumulated distributions | (864,932) | (847,120) | (829,307) | (811,493) |
| Accumulated other comprehensive income | (1,073) | (2,572) | (16) | (10) |
| Total stockholders' equity | 711,781 | 743,563 | 789,751 | 809,044 |
| Noncontrolling interest | 0 | 477 | 543 | 1,197 |
| Total equity | — | — | — | 810,761,000 |
| Total equity | 711,781 | 744,040 | 790,294 | — |
| Total liabilities and equity | 1,319,341 | 1,365,538 | 1,437,303 | 1,436,580 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.